We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 690 results
  1. Ozone alleviates MSU-induced acute gout pain via upregulating AMPK/GAS6/MerTK/SOCS3 signaling pathway

    Background

    Gout pain seriously affects the quality of patients' life. There is still no effective treatment. The inflammatory response is the main...

    Wen Fan, Chong Liu, ... Liang Hu in Journal of Translational Medicine
    Article Open access 08 December 2023
  2. Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial

    Background

    Growth arrest-specific 6 (GAS6) is a vitamin K-dependent protein related to inflammation, fibrosis, as well as platelet function. Genetic...

    Teng Ma, Rongrong Huang, ... Dachun Xu in Journal of Translational Medicine
    Article Open access 12 January 2023
  3. Anti-inflammatory clearance of amyloid-β by a chimeric Gas6 fusion protein

    Clearing amyloid-β (Aβ) through immunotherapy is one of the most promising therapeutic approaches to Alzheimer’s disease (AD). Although several...

    Hyuncheol Jung, Se Young Lee, ... Chan Hyuk Kim in Nature Medicine
    Article 04 August 2022
  4. GAS6/Axl is associated with AMPK activation and attenuates H2O2-induced oxidative stress

    Oxidative stress plays a key part in cardiovascular event. Growth arrest-specific gene 6 (GAS6) is a vitamin K-dependent ligand which has been shown...

    Zhenxing Liang, Yang Yang, ... **g Xu in Apoptosis
    Article 29 December 2022
  5. Gas6 Promotes Microglia Efferocytosis and Suppresses Inflammation Through Activating Axl/Rac1 Signaling in Subarachnoid Hemorrhage Mice

    Early brain injury (EBI) following  subarachnoid hemorrhage (SAH) is characterized by rapid development of neuron apoptosis and dysregulated...

    Junjia Tang, Yichao **, ... Qin Hu in Translational Stroke Research
    Article 03 November 2022
  6. LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p/miR-1296-5p and FUS

    Background

    Long non-coding RNAs (lncRNAs) are essential regulators of tumorigenesis and the development of colorectal cancer (CRC). Here, we aimed to...

    Qing Chen, Lin Zhou, ... Min Tao in Journal of Translational Medicine
    Article Open access 12 August 2022
  7. Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma

    Background

    Cabozantinib is an oral tyrosine kinase inhibitor in renal cell carcinoma (RCC), whose targets include oncogenic AXL and unique ligand...

    Kyohei Hakozaki, Nobuyuki Tanaka, ... Mototsugu Oya in British Journal of Cancer
    Article 05 October 2021
  8. GAS6-AS1, a long noncoding RNA, functions as a key candidate gene in atrial fibrillation related stroke determined by ceRNA network analysis and WGCNA

    Background

    Stroke attributable to atrial fibrillation (AF related stroke, AFST) accounts for 13 ~ 26% of ischemic stroke. It has been found that AFST...

    Rui-bin Li, **ao-hong Yang, ... Wei Cui in BMC Medical Genomics
    Article Open access 09 March 2023
  9. Gas6 induces inflammation and reduces plaque burden but worsens behavior in a sex-dependent manner in the APP/PS1 model of Alzheimer’s disease

    Background

    Alzheimer’s disease is the leading cause of dementia worldwide. TAM receptor tyrosine kinases (Tyro3, Axl, MerTK) are known for their role...

    Laura D. Owlett, Berke Karaahmet, ... M. Kerry O’Banion in Journal of Neuroinflammation
    Article Open access 07 February 2022
  10. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia

    Background

    Acute myeloid leukemia (AML) is the most common type of leukemia in adults. Its therapy has not significantly improved during the past...

    Hao Zhou, Wei Liu, ... Jianhua Zhu in Journal of Experimental & Clinical Cancer Research
    Article Open access 09 November 2021
  11. Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling

    Epidermal growth factor receptor ( EGFR ) gene amplification and mutation occurs most frequently in glioblastoma (GBM). However,...

    Minhai Dong, Qungen **ao, ... Baofeng Wang in Cancer Gene Therapy
    Article 28 January 2020
  12. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury

    Background

    Efferocytosis is a process that removes apoptotic cells and cellular debris. Clearance of these cells alleviates neuroinflammation,...

    Eman Soliman, John Leonard, ... Michelle H. Theus in Journal of Neuroinflammation
    Article Open access 09 November 2023
  13. Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications

    Background

    Occurrence of squamous cell carcinoma (SCC) even in early-stage, untreated chronic lymphocytic leukemia (CLL) patients can be a significant...

    Sutapa Sinha, Ray Guo, ... Neil E. Kay in British Journal of Cancer
    Article 17 June 2024
  14. Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis

    The capacity to survive and thrive in conditions of limited resources and high inflammation is a major driver of tumor malignancy. Here we identified...

    Selene E. Di Carlo, Jerome Raffenne, ... Lucie Peduto in Nature Immunology
    Article Open access 05 October 2023
  15. Identifying the Interaction Between Tuberculosis and SARS-CoV-2 Infections via Bioinformatics Analysis and Machine Learning

    The number of patients with COVID-19 caused by severe acute respiratory syndrome coronavirus 2 is still increasing. In the case of COVID-19 and...

    Ze-Min Huang, Jia-Qi Kang, ... Xu-Guang Guo in Biochemical Genetics
    Article 22 November 2023
  16. Tehranolid and Artemisinin Effects on Ameliorating Experimental Autoimmune Encephalomyelitis by Modulating Inflammation and Remyelination

    Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system. Artemisinin (ART) is a natural sesquiterpene lactone...

    Niloufar Salehi, Mitra Nourbakhsh, ... Afshin Zarghi in Molecular Neurobiology
    Article 30 June 2023
  17. Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness

    Both the tumor and tumor microenvironment (TME) are crucial for pathogenesis and chemotherapy resistance in multiple myeloma (MM). Bortezomib,...

    Seung-Hyun Jung, Sung-Soo Park, ... Chang-Ki Min in Experimental & Molecular Medicine
    Article Open access 15 November 2022
  18. Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma

    Background

    In the phase 3 METEOR trial, cabozantinib improved progression-free survival (PFS) and overall survival (OS) versus everolimus in patients...

    Thomas Powles, Toni K. Choueiri, ... Daniel J. George in BMC Cancer
    Article Open access 07 August 2021
Did you find what you were looking for? Share feedback.